The immunosuppressant tributyltin oxide blocks the mTOR pathway, like rapamycin, albeit by a different mechanism

Ahmed M. Osman, Henk van Loveren

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1361-1367
JournalJournal of Applied Toxicology
Volume34
Issue number12
DOIs
Publication statusPublished - Dec 2014

Keywords

  • TBTO
  • Rapamycin
  • m (TOR)
  • p70S6k1
  • 4E-BP1
  • mechanism

Cite this